Literature DB >> 21169320

Getting better value from the NHS drug budget.

James C Moon1, Andrew S Flett, Brian B Godman, Anthony M Grosso, Anthony S Wierzbicki.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21169320     DOI： 10.1136/bmj.c6449

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Policies to enhance prescribing efficiency in europe: findings and future implications.

Authors:  Brian Godman; William Shrank; Morten Andersen; Christian Berg; Iain Bishop; Thomas Burkhardt; Kristina Garuoliene; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Julie Lonsdale; Rickard E Malmström; Jaana E Martikainen; Vita Samaluk; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; Lesley Tilson; F Cankat Tulunay; Vera Vlahović-Palčevski; Kamila Wendykowska; Bjorn Wettermark; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2011-01-07       Impact factor: 5.810

2.  The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design.

Authors:  Amanj Baker; Li-Chia Chen; Rachel A Elliott; Brian Godman
Journal:  BMC Health Serv Res       Date:  2015-09-10       Impact factor: 2.655

Review 3.  Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Authors:  Brian Godman; Bjorn Wettermark; Menno van Woerkom; Jessica Fraeyman; Samantha Alvarez-Madrazo; Christian Berg; Iain Bishop; Anna Bucsics; Stephen Campbell; Alexander E Finlayson; Jurij Fürst; Kristina Garuoliene; Harald Herholz; Marija Kalaba; Ott Laius; Jutta Piessnegger; Catherine Sermet; Ulrich Schwabe; Vera V Vlahović-Palčevski; Vanda Markovic-Pekovic; Luka Vončina; Kamila Malinowska; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2014-06-17       Impact factor: 5.810

4.  Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.

Authors:  James C Moon; Brian Godman; Max Petzold; Samantha Alvarez-Madrazo; Kathleen Bennett; Iain Bishop; Anna Bucsics; Ulrik Hesse; Andrew Martin; Steven Simoens; Corinne Zara; Rickard E Malmström
Journal:  Front Pharmacol       Date:  2014-10-08       Impact factor: 5.810

5.  New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study.

Authors:  Richard Croker; Alex J Walker; Seb Bacon; Helen J Curtis; Lisa French; Ben Goldacre
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

6.  Prescriptive variability of drugs by general practitioners.

Authors:  Magda Bucholc; Maurice O'Kane; Siobhan Ashe; KongFatt Wong-Lin
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

7.  Toward effective prescription of inhaled corticosteroids in chronic airway disease.

Authors:  Zuzana Diamant; Guy Brusselle; Richard E Russell
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-18

8.  Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.

Authors:  Ben Goldacre; Carl Reynolds; Anna Powell-Smith; Alex J Walker; Tom A Yates; Richard Croker; Liam Smeeth
Journal:  BMJ Open       Date:  2019-02-05       Impact factor: 2.692

9.  Lost cost savings to the NHS in England due to the delayed entry of multiple generic low-dose transdermal buprenorphine: a case scenario analysis.

Authors:  Stephen Robert Chapman; Mohammed Ibrahim Aladul; Raymond William Fitzpatrick
Journal:  BMJ Open       Date:  2019-08-01       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.